Sign up to our newsletter and updates.
Intraday Hi-Lo:
52-Week Hi-Lo:
Related Companies:
Curated Stories & News
![marijuana stock news](https://marijuanastocks.com/wp-content/uploads/2014/09/NEWS-300x200.jpg)
$PMCB Receives Orphan Drug Designation
PharmaCyte Biotech Obtains Orphan Drug Designation in Europe for Its Pancre
![](https://marijuanastocks.com/wp-content/uploads/2015/02/top-marijuana-stocks-300x194.jpg)
Marijuana Stocks Gain Traction As March Roars On
For many marijuana stock investors and those looking for marijuana stocks t
![marijuana stocks news](https://marijuanastocks.com/wp-content/uploads/2014/09/NEWS2-300x200.jpg)
$PMCB Initiates Expanded Follow-up Study in the United States on the Accumulation of Malignant Ascites Fluid
PharmaCyte Biotech Initiates Expanded Follow-up Study in the United States
![marijuana stock news](https://marijuanastocks.com/wp-content/uploads/2014/09/NEWS-300x200.jpg)
$PMCB International Diabetes Consortium
PharmaCyte Biotech’s International Diabetes Consortium Sets Path Forw
![marijuana stocks news](https://marijuanastocks.com/wp-content/uploads/2014/09/NEWS2-300x200.jpg)
$PMCB Diabetes Treatment and How Will it Work
PharmaCyte Biotech’s Diabetes Treatment: How Would It Work? SAN DIEGO
![marijuana stocks news](https://marijuanastocks.com/wp-content/uploads/2014/09/NEWS2-300x200.jpg)
$PMCB Officially Begins Development of Diabetes Treatment
PharmaCyte Biotech Officially Begins Development of Diabetes Treatment With
![marijuana stocks](https://marijuanastocks.com/wp-content/uploads/2014/09/NEWS1-300x200.jpg)
$PMCB Partner Austrianova Opens New Facilities in Singapore
PharmaCyte Biotech’s Partner Austrianova Opens New Facilities in Sing
![marijuana stocks news](https://marijuanastocks.com/wp-content/uploads/2014/09/NEWS2-300x200.jpg)
$PMCB Follow-up Study on Malignant Ascites Fluid
PharmaCyte Biotech’s Expanded Follow-up Study on Malignant Ascites Fl